Showing results (2061-2070 of 2,622) with videos related to
Sort By:
Pageof 263
Therapeutic Advances in Infectious Disease|May 16, 2024
Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.CJennifer L Zack, Shawnika J Hull, Megan E Coleman, et al.Frontiers in Immunology|June 11, 2026
Systemic immune responses in patients with spine surgery related infectionsPia Fehrenbach, Siegmund Lang, Maja Gocević, et al.Headache|July 24, 2010
A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoringJoel R Saper, Alvin E Lake, Philip A Bain, et al.PM & R : the Journal of Injury, Function, and Rehabilitation|October 31, 2015
A Randomized Controlled Trial to Evaluate the Veterans' In-home Program for Military Veterans With Traumatic Brain Injury and Their Families: Report on Impact for Family MembersHelene Moriarty, Laraine Winter, Keith Robinson, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2019
Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated StatinDirk Müller-Wieland, Daniel J Rader, Patrick M Moriarty, et al.Journal of Medicinal Chemistry|September 13, 1996
A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationshipsF C Huang, W K Chan, K J Moriarty, et al.Journal of Medicinal Chemistry|September 13, 1996
Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chainW K Chan, F C Huang, M M Morrissette, et al.Expert Review of Anti-Infective Therapy|February 13, 2020
Fracture-related infection: current methods for prevention and treatmentAndrew L Foster, T Fintan Moriarty, Andrej Trampuz, et al.BMJ Open|June 20, 2025
Medicines support and social prescribing to address patient priorities in multimorbidity (MIDAS): protocol for a definitive, multi-arm, cluster randomised, controlled trial in Irish general practiceFarah Tahsin, Paul Doody, Barbara Clyne, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 5, 2025
An Economic Evaluation of Direct Oral Penicillin Challenge for De-Labelling Low Risk Patients With a Penicillin Allergy LabelR Bestwick, R Bhogal, K Kildonaviciute, et al.Pageof 263